Scientific Program | Third Global Summit on Precision Diagnosis for Prostate Cancer

8:00 AM

WELCOME AND INTRODUCTION:

Faina Shtern, MD, President and CEO, AdMeTech Foundation

Gerald Andriole, MD, Robert Royce Distinguished Professor, Chief of Urologic Surgery, and Vice-Chair, Department of Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, and Member, National Comprehensive Cancer Network (NCCN)’s Prostate Cancer Early Detection Panel

Richard Babayan, MD, Professor and Chairman, Department of Urology, Boston University School of Medicine; and Chief of Urology, Boston Medical Center

Michael Blute, MD, Walter S. Kerr, Jr. Professor of Urology and Surgery, Harvard Medical School; and Chief of Urology, Massachusetts General Hospital

8:30 AM
Q & A

8:35 AM
IsoPSA, a Novel Structure-Based Assay for Screening

Eric Klein, MD, Chairman, Glickman Urological and Kidney Institute, Cleveland Clinic

8:50 AM
Q & A

9:10 AM
Q & A

9:30 AM
Q & A

9:35 AM
Multi-Parametric (mp) Magnetic Resonance Imaging and PI-RADS for Risk Assessment Prior to Biopsy

Jeffrey Weinreb, MD, Professor and Vice Chair for Strategic Planning and Innovation, Department of Diagnostic Radiology and Biomedical Imaging,Yale School of Medicine

9:50 AM
mpMRI, PI-RADS and Multi-Modality Image Fusion for Target Definition and Tissue Sampling

Jelle Barentsz, MD, PhD, Chair and Professor of Radiology Prostate MR Center of Excellence, Nijmegen Medical Center, Radboud University, The Netherlands

10:10 AM – 10:30 AM
Coffee Break

10:45 AM
Q & A

11:20 AM
Q & A

12:30 PM – 1:30 PM
Lunch Break

David Crawford, MD, E. David Crawford Distinguished Endowed Chair in Urology, University of Colorado, Denver

Angelo DeMarzo, MD, PhD, Associate Professor of Pathology, Urology, Oncology, Johns Hopkins University School of Medicine

Eric Klein, MD, Chairman, Glickman Urological and Kidney Institute, Cleveland Clinic

2:10 PM
Q&A

2:15 PM
Radiogenomics of Tumor Habitats – Addressing Prostate Cancer Heterogeneity:

Radka Stoyanova, PhD, Professor and Director, Imaging and Biomarkers Research, Department of Radiation Oncology and Associate Member, Sylvester Comprehensive Cancer Center, Miller School of Medicine University of Miami

3:05 PM
Q&A

3:25 PM
Q&A

3:45 PM
Surrogate Outcomes

Jennifer Rider, ScD, MPH, Assistant Professor, Department of Epidemiology, Boston University School of Public Health

4:00 PM
Q&A

4:25 PM
Emerging Trends in Prostate Cancer Care: Impact of Precision Diagnostics 

Matthew Cooperberg, MD, MPH

4:40 PM
Q&A

4:45 PM
Radiogenomics: Emerging and Future Impact on Treatment Selection and Monitoring 

4:45 PM
Active Surveillance

Sanoj Punnen, MD

5:00 PM
Focal Treatment

Peter Pinto, MD

5:15 PM
Immediate Standard Whole Gland Treatment: Radical Prostatectomy and EBRT

Adam Feldman, MD, MPH, Assistant Professor of Surgery and Director of Combined Harvard Urology Oncology Fellowship, Massachusetts General Hospital, Harvard Medical School

5:40 PM – 6:30 PM

Panel on Diagnostic Evaluation of Men with Proven Localized Prostate Cancer and its Impact on Treatment Selection and Monitoring

Speakers, Moderators and Panel Members –

• Comments on Ultrasound and Multi-Modality Imaging – Sangeet Ghai, MD
• Comments on Improved Diagnosis of Clinically Significant PC – Susan Noworolski, PhD, Associate Professor, Department of Radiology, UCSF
• Comments on mpMRI for Cost-Effective Active Surveillance – Sejal Patel, MSc, Radboud University, The Netherlands
• Comments on Molecular Imaging – Heather Jacene, MD, Assistant Professor of Radiology and Associate Program Director, Brigham and Women’s Joint Program in Nuclear Medicine, Harvard Medical School
• Comments on Non-Invasive PSMA – Daniel Margolis, MD, Associate Professor of Radiology and Director, Prostate MRI and Abdominal Imaging, Weill Cornell Medicine
• Comments on Intraoperative Molecular Imaging for Staging –  Wolfgang Weber, MD, Professor and Chair,Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany
• Comments on Multi-Modality Novel Nomograms for Improved Risk Stratification – Amita Shukla-Dave, PhD, Deputy Service Chief for Predictive Informatics

Richard Frank, MD, PhD, Chief Medical Officer, Siemens Healthineers

Grannum R Sant, MD, FRCS, FACS, Professor and Former Chair of Urology, Tufts University School of Medicine; Former Head, Oncology/Urology Medical Affairs, Sanofi, and Rare Genetic Diseases, Genzyme

7:30 PM

Introduction: Four Hurdles to Adoption of Innovations into Clinical Practice 

Richard Frank, MD, PhD

7:55 PM

PET/CT with Axumin (18F-fluciclovine): Clinical Implementation

Blue Earth Diagnostics: Jonathan Allis, PhD, CEO

8:15 PM

Improving Prostate Biopsy Guidance: Moving to 29 MHz Micro-Ultrasound

Brian Wodlinger, PhD, Manager, Advanced Development and Clinical Research, Exact Imaging

8:20 PM

In Vitro Diagnostics: Clinical Adoption

Kelvin Moses, MD, PhD

8:40 PM

8:45 PM

Panel Discussion: Recommendations for Action to Accelerate Adoption

Moderators, Speakers and Peter Pinto, MD and Jeffrey Weinreb, MD

9:00 pm

Poster Session and Competition

8:00 AM

SESSION III: PRECISION DIAGNOSTICS AND EMERGING ROLE OF FOCAL TREATMENT

8:05 AM
Multimodality Precision Diagnostics for Target Definition

8:05 AM
MRI/Ultrasound Fusion

Srinivas Vourganti, MD, Urologic Oncologist, Department of Urology and Assistant Professor, Rush University Medical Center

8:15 AM
Multi-Modality Imaging

Sadhna Verma, MD, MD, FSAR, Professor of Radiology, Director, Prostate Imaging Program, University of Cincinnati Cancer Institute and the Veterans Administration Hospital

8:25 AM
Radiogenomics

John Feller, MD, Founder, Desert Medical Imaging

8:35 AM
Q&A

8:40 AM
Overview of Patient Selection, Monitoring and Outcomes

8:40 AM
Radiology Perspective

Jurgen Futterer, MD, PhD, Interventional Radiologist, Nijmegen Medical Center and Professor, University of Twente, The Netherlands

8:55 AM
Urology Perspective: Clinical Trial Design and Gold Nanoparticle-Directed Focal Ablation

Art Rastinehad, DO, FACOS, Associate Professor of Urology and Radiology, and Director, Focal Therapy and Interventional Urology Program, Icahn School of Medicine at Mount Sinai Health System

9:30 AM

SESSION IV: PRECISION ONCOLOGY FOR RECURRENT AND ADVANCED PROSTATE CANCER

Daniel Petrylak, MD, Professor of Medicine (Medical Oncology) and Urology; and Co-Director, Signal Transduction Research Program, Yale University Cancer Center

9:50 AM
Q&A

10:10 AM
Q&A

10:30 AM
Q&A

10:55 AM
Overview

Heather Jacene, MD, Assistant Professor of Radiology and Associate Program Director, Brigham and Women’s Joint Program in Nuclear Medicine, Harvard Medical School

12:00 PM
Q&A

1:30 PM

SESSION V: SUMMARY PANEL DISCUSSION

Session Leaders

Gerald Andriole, MD, Matthew Cooperberg, MD, MPH, David Crawford, MD, Angelo Demarzo, MD, PhD, Masoom Haider, MD, Eric Klein, MD, Daniel Petrylak, MD, Peter Pinto, MD, Faina Shtern, MD, Clare Tempany, MD, and Wolfgang Weber, MD